Advanced Fertility Institute to Offer Pioneering Test of a Woman's Biological Clock
Plan Ahead(TM) Test Offers Most Accurate Measurement of a Woman's Biological Clock
Mar. 18, 2008 07:17 PM
COLUMBIA, SC -- (MARKET WIRE) -- 03/18/08 -- Advanced Fertility & Reproductive
Endocrinology Institute, LLC today announced it will offer the Repromedix's
PlanAhead™ test, an innovative blood test that provides an assessment of a
woman's egg supply by combining multiple factors including the measurement
of ovary-related hormones AMH, Inhibin B, and FSH. The window of
opportunity for a woman to have children by natural conception is dependent
upon an adequate supply of eggs which inevitably declines as a woman ages
and her "biological clock ticks." PlanAhead enables a woman to compare
her estimated egg supply with the normal range expected for women of the
same age. In addition, the PlanAhead Report provides valuable directional
information about women planning to have children after their late twenties
and for those that need to seek further advice from fertility experts to
help ensure that they can have their own biological family they were hoping
for.
"Advanced Fertility Institute has always incorporated the latest assisted
reproductive technologies (ART) into our treatment plans to give our
patients the best chance possible of having a baby," said Gail
Whitman-Elia, M.D., Medical Director of Advanced Fertility Institute. "We
strive to provide our patients with the most advanced testing and treatment
options, and PlanAhead will provide women with the individual assessment of
their own ovarian reserve to help them make more informed decisions about
when to have a child. We're pleased to be in the vanguard of this critical
new test."
Repromedix Corp., the PlanAhead test co-developer and leading national
diagnostic laboratory for fertility testing, selected Advanced Fertility
Institute to be one of a select number of IVF centers to debut the test.
Repromedix will expand the PlanAhead launch to major markets across the
United States throughout 2008.
PlanAhead is now available to women in the greater Columbia, SC area, and
women interested in the PlanAhead test can purchase a test online at
www.planaheadtest.com/us or at Advanced Fertility Institute, where they can
also have their blood drawn. The blood sample is sent to Repromedix, whose
lab performs the advanced testing and submits the report and
recommendations to the patient's physician. The cost of the PlanAhead test
is $350.
Advanced Fertility & Reproductive Endocrinology is an award-winning,
leading provider of full-service fertility therapy for the Southeast. Under
the direction of Gail Whitman-Elia, M.D., FACOG, the practice has
established a reputation for consistently high results and top-level,
compassionate care.
Repromedix is the leading national diagnostic laboratory for fertility
testing and offers a multifaceted approach to clinical fertility testing
that encompasses many medical disciplines including endocrinology,
immunology and genetics. Repromedix offers the most comprehensive suite of
advanced diagnostic tests that provide valuable information regarding the
complex problems of reproductive failure. Since its inception in 1993, the
company has assisted more than 45,000 patients by performing over 100,000
diagnostic tests for recurrent pregnancy loss, premature ovarian failure,
male infertility, and unexplained infertility. Repromedix is a portfolio
company of Brook Venture Partners, Ironwood Capital Management, and Brooke
Private Equity Advisors.
Contact:
Mike Burney
803-238-0300 Email Contact
SUBSCRIBE TO THE WORLD'S MOST POWERFUL NEWSLETTERS
SUBSCRIBE TO OUR RSS FEEDS & GET YOUR SYS-CON NEWS LIVE!
Click to Add our RSS Feeds to the Service of Your Choice:
.gif)
